Pagni, B. A.
Petridis, P. D.
Podrebarac, S. K.
Grinband, J.
Claus, E. D.
Bogenschutz, M. P.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study
https://doi.org/10.1038/s41598-024-52967-8
Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.
https://doi.org/10.1037/adb0000935
Funding for this research was provided by:
Heffter Research Institute
Clinical and Translational Science Institute, New York University (UL1 TR000038)
Article History
Received: 23 October 2023
Accepted: 25 January 2024
First Online: 7 February 2024
Competing interests
: BAP is a postdoctoral fellow in the NYU Langone Psychedelic Medicine Research Training program funded by MindMed and is supported by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number TL1TR001447. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. PDP, SKP, JG, and EDC report no competing interests.